Arkolith/Insider Trading/RNAZ/Form 4

Dudley Robert Michael

Chief Executive Officer, DirectorTranscode Therapeutics, Inc. (RNAZ) · full profile →Form 4 · filed Oct 2, 2023
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 28, 2023Buy(P)98K$0.51$50K180K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-105924) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML